pharmaphorum
JUNE 15, 2022
The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. The industry is uniting to address mechanisms of drug resistance, spearhead progress in molecular subtyping and define practice-changing drug sequencing and combinations for the largest solid tumor indication, NSCLC.
PharmaVoice
JUNE 15, 2022
Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 15, 2022
Tech startup Proximie has raised $80 million in third-round financing that will be used to further develop its augmented reality platform, which allows surgeons to share best practices with other clinicians anywhere in the world. The London, UK-based company’s connected operating room (OR) platform means doctors can physically show each other where to make an incision – in real-time – or use physical gestures to illustrate a technique.
Board Vitals - Pharmacist
JUNE 15, 2022
Physicians aren’t alone in their continuing education requirements. Nursing continuing education is required in most states to ensure that nurses and nurse practitioners keep their knowledge up to date. What do you need to know about CME for nurses, and how can you fulfill your requirements? . Why Do Nurses Need to Earn Continuing Education? . As the medical industry advances, so must the knowledge nurses have.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JUNE 15, 2022
Astellas’ oral HIF-PH inhibitor Evrenzo has become the first drug in the class to be recommended for routine NHS use as a treatment for anaemia in chronic kidney disease (CKD), ahead of rivals from Otsuka and GlaxoSmithKline. The decision by cost-effectiveness watchdog NICE means that Evrenzo (roxadustat) is the first oral alternative to treatment with injectable iron supplements or erythropoietin-based therapies symptomatic anaemia associated with CKD.
NICE
JUNE 15, 2022
By Jeanette Kusel, director of scientific advice, Mark Salmon, programme director of information resrouces and Sarah Byron, interim programme director for devices, diagnostics and digital at NICE. The explosion in digital health products has left NHS commissioners wondering how they can possibly sift out what works and what provides maximum benefit for the service and for patients.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
NICE
JUNE 15, 2022
I’ve seen many changes to the health and care landscape since I’ve been at NICE – some more significant than others. But I feel that the point we’re at now is particularly striking. New, innovative, and potentially disruptive treatments are being developed at a pace we haven’t seen before – leading to medicines of great range and complexity.
Digital Pharmacist
JUNE 15, 2022
Men’s health week is upon us and we are thrilled to be raising awareness with you. The goal of this week is to focus on encouraging boys, men, and their families to practice and implement healthy living decisions, such as exercising and eating plenty of fruits and vegetables. Focusing on men’s health and raising awareness is imperative as we strive to keep our communities healthy.
NICE
JUNE 15, 2022
Innovative medicines, medical devices and diagnostics are arriving at an unprecedented pace. At NICE, it’s our duty to keep ahead of these developments to make sure patients gain rapid access to the most promising, cutting-edge treatments. So, we’re taking a number of measures to address this. These include developing a proportionate approach to technology appraisals to increase our capacity.
pharmaphorum
JUNE 15, 2022
Over the last half-decade, we have witnessed game-changing developments within the cannabinoid field, driving it into a new era of rigorous research, promising clinical trials and multimillion-dollar deals. The 5 th International Cannabinoid-Derived Pharmaceuticals Summit brings together drug developers working on the complex production of both plant-based, biosynthetic and synthetic endocannabinoid system modulators.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
JUNE 15, 2022
Unveiled at the 2022 BIO International Convention, the group's third annual diversity, equity, and inclusion report spotlights improvements both made and needed.
PharmExec
JUNE 15, 2022
Larger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success.
Med Ed 101
JUNE 15, 2022
Converting Risperidone to Other Antipsychotics Lifelong antipsychotic therapy is often needed to adequately manage psychiatric conditions. Unfortunately, therapy often needs to be adjusted to optimize efficacy while avoiding undesirable side effects. Risperidone (Risperdal) is a second-generation antipsychotic (SGA) commonly used in practice but tends to have a higher risk of producing certain adverse effects compared […].
Pharma Times
JUNE 15, 2022
Jazz Pharmaceuticals and Redx announce that pan-RAF inhibitor will enter clinical development
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Commerce
JUNE 15, 2022
Focus on operational excellence is playing a major role in this effort, company says.
Pharma Times
JUNE 15, 2022
The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide
Pharma Manufacturing
JUNE 15, 2022
Three priorities for re-strategizing digital transformation post-COVID
Pharmaceutical Commerce
JUNE 15, 2022
CDMO’s Ireland campus will increase in capacity by 50% as a result.
pharmaphorum
JUNE 15, 2022
Boehringer Ingelheim must like what it has seen in its two-year-old R&D collaboration with Trutino Biosciences to develop cytokine therapies – it has just taken an option to buy the company outright. The German pharma group originally teamed up with San Diego-based Trutino on a project to apply its drug discovery and development platform to three undisclosed cytokines, making them safer and potentially more effective as treatments for cancer as they could be administered at higher doses.
Compounding Pharmacy of America
JUNE 15, 2022
A single bad night’s sleep is common once in a while, but it should not be the norm. If you have a hard time sleeping more than a few times a week, whether that’s getting to sleep or staying asleep, be sure to seek medical help. The post How to Get Better Sleep Throughout the Night appeared first on The Compounding Pharmacy of America.
Expert insights. Personalized for you.
105 
Let's personalize your content